Labor analgesia effectiveness varies significantly among patients due to underlying genetic factors. Specifically, recent findings highlight the miR-124 polymorphism labor analgesia connection as a key determinant of sufentanil efficacy in primiparous women. This genetic variation specifically influences how patients respond to epidural treatments during childbirth.

In a retrospective study, investigators examined 100 primiparas receiving sufentanil. They identified three distinct genotypes for the miR-124 rs531564 polymorphism: CC, CG, and GG. Notably, the CC genotype appeared in over half of the participants. These individuals exhibited significantly higher VAS scores one hour after drug administration. Consequently, this indicates a suboptimal analgesic response compared to those carrying the G allele.

Impact of miR-124 Polymorphism Labor Analgesia on Drug Metabolism

The study further explored the biological mechanisms behind these results. Patients with the CC genotype demonstrated lower miR-124 expression levels. Moreover, these women had lower sufentanil blood concentrations during the mid-phase of administration. This suggests that the C allele may trigger faster drug clearance or metabolism. Therefore, clinicians might observe diminished pain relief in these specific patients. Conversely, the presence of the G allele correlated with higher plasma levels and improved clinical outcomes. Furthermore, lower 1-minute Apgar scores in the CC group suggest potential neonatal implications that warrant further investigation.

Ultimately, understanding these genetic markers allows for a more personalized approach to obstetric anesthesia. Future protocols may integrate microRNA screening to optimize dosing strategies. This ensures that every mother receives the most effective pain management during labor.

Frequently Asked Questions

How does the CC genotype affect labor pain management?

Women with the CC genotype of miR-124 often experience less effective pain relief from sufentanil. This is characterized by higher pain scores and lower drug concentrations in the blood shortly after administration.

Can genetic testing improve labor analgesia?

Yes, identifying polymorphisms like miR-124 rs531564 can help anesthesiologists tailor drug dosages. This personalized approach aims to achieve better pain control and improve safety for both the mother and the newborn.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Long L et al. Association of miR-124 polymorphism with labor analgesia in primiparas. Ginekol Pol. 2026 Jun 09. doi: 10.5603/gpl.107187. PMID: 42261727.

Chen Y, et al. Comparative efficacy of opioid and non-opioid analgesics in labor pain management: A network meta-analysis. PLOS One. 2024;19(6):e0303174.

Shen Y, et al. Exploration of the relationship between miR-146a rs2910164 polymorphisms and the efficacy of epidural fentanyl in labor analgesia among pregnant women. J Matern Fetal Neonatal Med. 2026;39(1):2650241.